How to Help Your Patients Find Follistim in Stock: A Provider's Guide

As a fertility provider, you know that medication access can make or break a treatment cycle. Follistim AQ (Follitropin Beta) is one of the most commonly prescribed gonadotropins for IVF and ovulation induction, and your patients are increasingly reporting trouble finding it at their pharmacies.

This guide offers a practical, step-by-step approach to helping your patients get the Follistim they need — and what to do when they can't.

Current Availability Landscape

Follistim AQ is manufactured exclusively by Organon. It is not on the FDA's official drug shortage list as of 2026, but supply is unevenly distributed across the pharmacy network:

• Specialty fertility pharmacies generally maintain reliable stock and should be the first point of contact
• Hospital outpatient pharmacies at major fertility centers often carry Follistim
• Retail pharmacies (CVS, Walgreens, etc.) rarely stock Follistim and may require 3-7 days to special order
• Regional variation exists — larger metro areas with more fertility clinics tend to have better availability through specialty channels

For the broader supply picture, see our companion article: Follistim Shortage: What Providers and Prescribers Need to Know in 2026.

Why Patients Can't Find Follistim

Understanding the root causes helps you anticipate and address patient concerns:

1. Patients Default to Retail Pharmacies

Many patients naturally try to fill their prescriptions at the same pharmacy they use for everything else. Since Follistim is a cold-chain specialty biologic, retail pharmacies typically don't carry it. Patients may not realize they need a specialty pharmacy until they've already lost valuable time.

2. Insurance Routing Complications

Some insurance plans require patients to use specific specialty pharmacies. If the patient doesn't know which pharmacy their plan mandates — or if that pharmacy has a temporary stock issue — it creates delays. Prior authorization requirements add another layer of complexity.

3. Late Prescription Timing

Prescriptions submitted close to cycle start leave little margin for supply issues. When a pharmacy doesn't have stock, there isn't enough time to source it from elsewhere without risking cycle cancellation.

4. Limited Manufacturer

With Organon as the sole US manufacturer and no generic or biosimilar available, any production or distribution disruption has an outsized impact on availability.

What Providers Can Do: 5 Actionable Steps

Step 1: Submit Prescriptions Early

Make it a practice standard to submit Follistim prescriptions to the patient's specialty pharmacy at least 7-10 days before anticipated cycle start. This provides adequate time for:

• Insurance verification and benefits investigation
• Prior authorization processing (if required)
• Stock confirmation and ordering if needed
• Temperature-controlled shipping to the patient

Step 2: Direct Patients to Specialty Pharmacies

Maintain an updated list of specialty fertility pharmacies your practice works with. Include:

• Freedom Fertility Pharmacy
• Avella Specialty Pharmacy
• Alto Pharmacy
• MDR Pharmacy
• Village Fertility Pharmacy

Share this list with patients at their treatment planning appointment — don't wait until stimulation day.

Step 3: Use Real-Time Availability Tools

Rather than having your nursing staff spend time calling pharmacies, direct patients to Medfinder for Providers. The platform provides real-time pharmacy stock data for Follistim and other fertility medications, saving your staff time and giving patients immediate, actionable information.

Step 4: Maintain Protocol Flexibility

Build flexibility into your stimulation protocols to accommodate potential medication switches. Having pre-approved alternative protocols using Gonal-F (Follitropin Alfa) or Menopur (Menotropins) means you can pivot quickly if Follistim is unavailable. Document these alternative protocols in your practice's clinical guidelines so any provider in your group can implement them consistently.

Step 5: Connect Patients With Financial Resources

Cost is often intertwined with access — patients who can't afford Follistim at one pharmacy may be able to access it through savings programs. Key resources to share:

• ReUnite Rx (Organon): 25-75% savings for eligible cash-paying patients. Email info@reuniterx.com or visit reuniterx.com.
• Livestrong Fertility: Discounted medications for cancer patients preserving fertility
• Baby Quest Foundation: Grants for fertility treatment costs
• State-specific programs: Many states have assistance programs for fertility patients

For a detailed overview you can share with patients, see: How to Save Money on Follistim in 2026.

Alternatives to Follistim

When Follistim is genuinely unavailable, the following alternatives are clinically appropriate:

• Gonal-F (Follitropin Alfa): The most direct substitute. Recombinant FSH with well-established equivalence in IVF outcomes. Available in pre-filled pens (300, 450, 900 IU) and multi-dose vials. Can typically be substituted at the same IU dose.
• Menopur (Menotropins): Purified urinary FSH + LH. Particularly useful for patients who benefit from LH supplementation. Often used in combination protocols but can serve as a standalone gonadotropin.
• Pergoveris (Follitropin Alfa + Lutropin Alfa): Combination recombinant FSH/LH for patients with severe gonadotropin deficiency.

For a patient-friendly comparison, share our article on alternatives to Follistim.

Workflow Tips for Your Practice

Integrating medication access management into your clinical workflow can prevent cycle disruptions:

• Treatment planning visit: Provide patients with specialty pharmacy contacts and Medfinder information. Discuss the possibility of medication switches upfront.
• Baseline monitoring: Confirm with the patient that they have their medications in hand (or confirmed for delivery) before proceeding with stimulation.
• Mid-cycle dose changes: If you adjust the dose and the patient needs additional cartridges, alert the pharmacy immediately — don't leave this to the patient alone.
• Post-cycle debrief: Note any medication access issues in the patient's chart so you can plan differently for future cycles.
• Staff training: Ensure your nursing and administrative staff understand the specialty pharmacy landscape and can triage medication access issues efficiently.

Final Thoughts

Medication access is increasingly a clinical concern, not just an administrative one. By planning ahead, using the right tools, maintaining protocol flexibility, and connecting patients with financial resources, you can minimize the impact of Follistim supply challenges on your patients' fertility journeys.

For more provider-focused resources, visit Medfinder for Providers. For a broader view of the supply situation, see our Follistim shortage briefing for providers.